ECMO Platform Overview. Acute Hypoxemic Respiratory Failure. Atrial Septal Defects
ECMO Platform Overview. Acute Hypoxemic Respiratory Failure. Atrial Septal Defects

ECMO Platform Overview. Acute Hypoxemic Respiratory Failure. Atrial Septal Defects [282]

  • Faculty: John Ingram, CCP; Jordan Hoffman, MD; John Poland, CCP
  • Date: June 2nd, 2021 6:45 am
  • CEU’s: 3.4 CEUs
  • Price: $51
  • Category 3 CEU
Buy Course
Course Rating:
(0 Reviews)

Latest Reviews

View All

Course description

Vanderbilt University Medical Center; Department of CV Surgery: Faculty Forum - ECMO platform overview: Cost, safety, versatility

 Tammy Sparacino Journal Club: Lower or Higher Oxygenation Targets for Acute Hypoxemic Respiratory Failure 
"BACKGROUND Patients with acute hypoxemic respiratory failure in the intensive care unit (ICU) are treated with supplemental oxygen, but the benefits and harms of different oxygenation targets are unclear. We hypothesized that using a lower target for partial pressure of arterial oxygen (Pao2) would result in lower mortality than using a higher target. METHODS: In this multicenter trial, we randomly assigned 2928 adult patients who had recently been admitted to the ICU (≤12 hours before randomization) and who were receiving at least 10 liters of oxygen per minute in an open system or had a fraction of inspired oxygen of at least 0.50 in a closed system to receive oxygen therapy targeting a Pao2 of either 60 mm Hg (lower-oxygenation group) or 90 mm Hg (higher-oxygenation group) for a maximum of 90 days. The primary outcome was death within 90 days. RESULTS At 90 days, 618 of 1441 patients (42.9%) in the lower-oxygenation group and 613 of 1447 patients (42.4%) in the higher-oxygenation group had died (adjusted risk ratio, 1.02; 95% confidence interval, 0.94 to 1.11; P=0.64). At 90 days, there was no significant between-group difference in the percentage of days that patients were alive without life support or in the percentage of days they were alive after hospital discharge. The percentages of patients who had new episodes of shock, myocardial ischemia, ischemic stroke, or intestinal ischemia were similar in the two groups (P=0.24). CONCLUSIONS Among adult patients with acute hypoxemic respiratory failure in the ICU, a lower oxygenation target did not result in lower mortality than a higher target at 90 days. (Funded by the Innovation Fund Denmark and others" 
John Ingram Knowledge Nuggets: Atrial Septal Defects 
Register and watch for free @ 
IV Dosage and Rate Calculator - 

Meet Your Instructor

John Ingram, CCP

John Ingram, CCP

John Ingram is a magna cum laude graduate from University of Texas, Texas Heart Institute and a board certified perfusionist currently specializing in adult perfusion as well as pediatric and adult ECMO.  He has several medical patents and has served as a consultant for nearly every perfusion manufacturer. He has published seven research publications in the perfusion literature, and has presented both nationally and internationally.   With fifteen years experience as a Chief Perfusionist, and thirty years perfusion experience in total, he presently provides nationwide temporary and long term locum tenens coverage.

Read Full Bio
Jordan Hoffman, MD

Jordan Hoffman, MD

Dr. Hoffman was born in New Orleans, Louisiana and was raised in Los Angeles, California. His undergraduate degree is from Rice University in Houston, Texas. He attended medical school at Tulane University in New Orleans, Louisiana and simultaneously received his MPH from the Tulane School of Public Health and Tropical Medicine. Dr. Hoffman’s general surgical training began at Emory and Grady Hospitals in Atlanta, Georgia followed by a fellowship in Cardiothoracic Surgery at University of Colorado in Denver, Colorado. 

Dr. Hoffman's clinical interests include end-stage heart and lung disease, pulmonary hypertension, mechanical support and devices, as well as aortic surgery. His research interests involve studying heart failure physiology in patient’s undergoing LVAD placement and novel therapies to extend the viability of donor hearts.

Read Full Bio
John Poland, CCP

John Poland, CCP

Vanderbilt University Medical Center Cardiopulmonary Perfusionist 

· Responsible for Heart Lung Machine · ECMO Patients – transport, bedside monitoring
· Work directly with Surgeon, Anesthesia and Surgical Team

Vanderbilt University Medical Center
Certified Anesthesia Technician/Evening Coordinator, Nashville
· Worked directly with Anesthesiologists, Residents, and CRNA’s.
· Excellent understanding of Aseptic Technique.
· Trained new technicians in all aspects of job.
· Cell Saver Certified, working directly with surgeons.
· Knowledgeable of Anesthesia machine and equipment.

Read Full Bio